Michael A Barras (Michael Barras)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 14

Top Topics

Venous Thromboembolism

Direct Oral Anticoagulants

Top Venues

Internal medicine journal

Antimicrobial agents and chemotherapy

Clinical drug investigation

Journal of thrombosis and thrombolysis

This page only lists publications with an associated author ORCID identifier.

Publications

Nameer Van Oosterom, Michael A Barras, Neil W Cottrell
Prevalence of risk factors for venous thromboembolism and aspirin resistance in Australian patients undergoing total hip and knee arthroplasty. Internal medicine journal (2024)
Nameer Van Oosterom, Michael A Barras, Neil W Cottrell
Prevalence of risk factors for venous thromboembolism and aspirin resistance in Australian patients undergoing total hip and knee arthroplasty. Internal medicine journal 54 (8) (2024)
Martin Luke Canning, Ross McDougall, Stephanie T Yerkovich, Michael A Barras, Ian D Coombes, Clair Sullivan, Karen Whitfield
Measuring the impact of pharmaceutical care bundle delivery on patient outcomes: an observational study. International journal of clinical pharmacy (2024)
Centaine L Snoswell, Keshia R De Guzman, Michael A Barras
Advanced-scope pharmacist roles in medical outpatient clinics: a cost-consequence analysis. Internal medicine journal (2023)
Ahmad Abdel-Hafez, Ian A Scott, Nazanin Falconer, Stephen Canaris, Oscar Bonilla, Sven Marxen, Aaron Van Garderen, Michael A Barras
Predicting Therapeutic Response to Unfractionated Heparin Therapy: Machine Learning Approach. Interactive journal of medical research 11 (2) (2022)
Jonathan Yong Jie Lam, Michael A Barras, Ian A Scott, Duncan Long, Leila Shafiee Hanjani, Nazanin Falconer
Scoping Review of Studies Evaluating Frailty and Its Association with Medication Harm. Drugs & aging 39 (5) (2022)
Nameer Van Oosterom, Michael A Barras, Robert J Bird, Iulian Nusem, Neil W Cottrell
A Narrative Review of Aspirin Resistance in VTE Prophylaxis for Orthopaedic Surgery. Drugs 80 (18) (2021)
Yanhua Gao, Stefanie Hennig, Michael A Barras
Monitoring of Tobramycin Exposure: What is the Best Estimation Method and Sampling Time for Clinical Practice? Clinical pharmacokinetics 58 (3) (2020)
Nameer Van Oosterom, Karl Winckel, Michael A Barras
Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity. Journal of thrombosis and thrombolysis 48 (3) (2020)
Nameer Van Oosterom, Karl Winckel, Michael A Barras
Comment On: "Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study". Clinical drug investigation 40 (3) (2020)
Yanhua Gao, Michael A Barras, Stefanie Hennig
Bayesian Estimation of Tobramycin Exposure in Patients with Cystic Fibrosis: an Update. Antimicrobial agents and chemotherapy 62 (3) (2018)
Nazanin Falconer, Michael A Barras, Neil W Cottrell
Systematic review of predictive risk models for adverse drug events in hospitalized patients. British journal of clinical pharmacology 84 (5) (2018)
Michael A Barras, David Hughes, Melanie Ullner
Direct oral anticoagulants: New drugs with practical problems. How can nurses help prevent patient harm? Nursing & health sciences 18 (3) (2016)
Michael A Barras, David Serisier, Stefanie Hennig, Katrina Jess, Ross L G Norris
Bayesian Estimation of Tobramycin Exposure in Patients with Cystic Fibrosis. Antimicrobial agents and chemotherapy 60 (11) (2016)